Effectiveness and safety of rituximab for the treatment of refractory systemic sclerosis associated calcinosis: A case series and systematic review of the literature.
Sign Up to like & getrecommendations! Published in 2019 at "Autoimmunity reviews"
DOI: 10.1016/j.autrev.2018.10.006
Abstract: OBJECTIVE To analyze the effectiveness and safety of rituximab (RTX) for the treatment of refractory systemic sclerosis (SSc)-associated calcinosis. METHODS We undertook an observational study of patients with this complication treated with 1 or more… read more here.
Keywords: effectiveness safety; treatment refractory; rtx; safety rituximab ... See more keywords
Efficacy and safety of rituximab in relapsing-remitting multiple sclerosis: A systematic review and meta-analysis
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Neuroimmunology"
DOI: 10.1016/j.jneuroim.2020.577317
Abstract: OBJECTIVE This study aimed to quantitatively review and summarize the effectiveness and safety of rituximab (RTX) treatment for patients with relapsing-remitting multiple sclerosis (RRMS). METHODS PubMed, Embase, the Cochrane Library, and ClinicalTrials.gov databases were searched,… read more here.
Keywords: rituximab; relapsing remitting; treatment; safety ... See more keywords
Efficacy and Safety of Rituximab in the Treatment of Idiopathic Membranous Nephropathy: A Meta-Analysis
Sign Up to like & getrecommendations! Published in 2022 at "Applied Bionics and Biomechanics"
DOI: 10.1155/2022/5393797
Abstract: Background Primary membranous nephropathy (MN), sometimes referred to as idiopathic membranous nephropathy (IMN), is a kind of MN whose pathogenesis is yet unclear. According to research reports, the incidence of IMN is about 9.8–26.8%, and… read more here.
Keywords: meta analysis; idiopathic membranous; safety rituximab; analysis ... See more keywords
Efficacy and safety of rituximab in patients with multiple sclerosis
Sign Up to like & getrecommendations! Published in 2022 at "Neurosciences"
DOI: 10.17712/nsj.2022.2.20210122
Abstract: Objectives: To assess the efficacy and safety of rituximab for multiple sclerosis (MS) treatment in terms of reduction in clinical relapses, magnetic resonance imaging (MRI) activity, Expanded Disability Status Scale (EDSS) score and adverse events.… read more here.
Keywords: efficacy safety; safety rituximab; safety; multiple sclerosis ... See more keywords